Motoh Iwasa, Ryosuke Sugimoto, Akiko Eguchi, Yasuyuki Tamai, Ryuta Shigefuku, Naoto Fujiwara, Hideaki Tanaka, Yoshinao Kobayashi, Jiro Ikoma, Masahiko Kaito, et al. Effectiveness of 1-year pemafibrate treatment on steatotic liver disease: the influence of alcohol consumption. European journal of gastroenterology & hepatology. 2024. 36. 6. 793-801
Yasuyuki Tamai, Naoto Fujiwara, Takamitsu Tanaka, Shugo Mizuno, Hayato Nakagawa. Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma. Cancers. 2023. 15. 20. 5072-5072
Toshiharu Onodera, May-Yun Wang, Joseph M. Rutkowski, Stanislaw Deja, Shiuhwei Chen, Michael S. Balzer, Dae-Seok Kim, Xuenan Sun, Yu A. An, Bianca C. Field, et al. Endogenous renal adiponectin drives gluconeogenesis through enhancing pyruvate and fatty acid utilization. Nature Communications. 2023. 14. 1
Sandra Santasusagna, Shijia Zhu, Vijayakumar Jawalagatti, Marc Carceles-Cordon, Adam Ertel, Saioa Garcia-Longarte, Won-Min Song, Naoto Fujiwara, Peiyao Li, Isabel Mendizabal, et al. Master transcription factor reprograming unleashes selective translation promoting castration resistance and immune evasion in lethal prostate cancer. Cancer Discovery. 2023
Yuta Sekino, Ryosuke Tateishi, Nobuyoshi Fukumitsu, Toshiyuki Okumura, Kazushi Maruo, Takashi Iizumi, Haruko Numajiri, Masashi Mizumoto, Tatsuya Minami, Ryo Nakagomi, et al. Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis. Liver cancer. 2023. 12. 4. 297-308
Naoto Fujiwara, Austin J. Fobar, Indu Raman, Quan-Zhen Li, Jorge A. Marrero, Neehar D. Parikh, Amit G. Singal, Yujin Hoshida. A Blood-Based Prognostic Liver Secretome Signature Predicts Long-term Risk of Hepatic Decompensation in Cirrhosis. Clinical Gastroenterology and Hepatology. 2021
Naoto Fujiwara, Yujin Hoshida. Viral Exposure Signature Associated with Liver Cancer Risk. Trends in Molecular Medicine. 2020. 26. 8. 711-713